| Scrip Code | 543245 |
|---|---|
| NSE Symbol | GLAND |
| MSEI Symbol | NOTLISTED |
| ISIN | INE068V01023 |
| Name of company | GLAND PHARMA LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 28-01-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 09-01-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Pharmaceuticals |
| Start date and time of board meeting | 28-01-2026 15:00:00 |
| End date and time of board meeting | 28-01-2026 16:15:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | No |
| No. of times funds raised during the quarter | |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| NA | |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| 1 | Income | ||
| Revenue from operations | 1,17,751.30 | 3,29,050.00 | |
| Other income | 6,020.70 | 19,754.00 | |
| Total income | 1,23,772.00 | 3,48,804.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 43,484.80 | 1,33,426.20 |
| (b) | Purchases of stock-in-trade | 150.10 | 432.60 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 2,793.20 | (2,821.90) |
| (d) | Employee benefit expense | 13,414.20 | 39,486.20 |
| (e) | Finance costs | 50.20 | 1,190.80 |
| (f) | Depreciation, depletion and amortisation expense | 4,453.00 | 13,313.30 |
| (f) | Other Expenses | ||
| 1 | Power and fuel | 2,953.90 | 9,255.90 |
| 2 | Other expenses | 12,792.40 | 33,735.10 |
| Total other expenses | 15,746.30 | 42,991.00 | |
| Total expenses | 80,091.80 | 2,28,018.20 | |
| 3 | Total profit before exceptional items and tax | 43,680.20 | 1,20,785.80 |
| 4 | Exceptional items | (2,434.60) | (2,434.60) |
| 5 | Total profit before tax | 41,245.60 | 1,18,351.20 |
| 6 | Tax expense | ||
| 7 | Current tax | 11,020.60 | 30,937.50 |
| 8 | Deferred tax | (559.70) | (496.30) |
| 9 | Total tax expenses | 10,460.90 | 30,441.20 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 30,784.70 | 87,910.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 30,784.70 | 87,910.00 |
| 17 | Other comprehensive income net of taxes | 20.20 | 88.40 |
| 18 | Total Comprehensive Income for the period | 30,804.90 | 87,998.40 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | |||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 1,647.60 | 1,647.60 | |
| Face value of equity share capital | 1 | 1 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 18.68 | 53.36 | |
| Diluted earnings (loss) per share from continuing operations | 18.68 | 53.36 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 18.68 | 53.36 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 18.68 | 53.36 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | IntermsofRegulation33oftheSEBIListingObligationsandDisclosureRequirementsRegulations2015asamendedtheListingrequirementsthisStatementofUnauditedStandaloneFinancialResultsforthequarterandninemonthsendedDecember312025StandaloneFinancialResultsoftheCompanyhasbeenreviewedbytheAuditCommitteeandapprovedbytheBoardofDirectorsattheirmeetingsheldonJanuary282026ThestatutoryauditorshavecarriedoutalimitedreviewontheUnauditedStandaloneFinancialResultsandissuedanunmodifiedreportthereonReferthesignedresultsuploadedforthecompletenotes |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Standalone | Standalone | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of defined benefit plans | 27.10 | 118.20 |
| Total Amount of items that will not be reclassified to profit and loss | 27.10 | 118.20 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 6.90 | 29.80 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 20.20 | 88.40 |
| Whether results are audited or unaudited | Unaudited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | Deloitte Haskins & Sells | Yes | 30-04-2028 | ||
|---|---|---|---|---|---|